Abstract: The present invention provides compounds of Formula (I) wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present disclosure provides a packet transmission method and apparatus. The method includes: a classifier receiving a first packet; the classifier determining a first service function (SF) to which the first packet is to be transmitted; the classifier adding an address of the first SF to the first packet, obtaining a second packet; and the classifier transmitting the second packet to a network virtualization edge (NVE) node.

Abstract: Provided are a method and device for processing a data message. The method may include that: an Internet Protocol version 6 (IPv6) transition strategy used for executing an IPv6 transition technology is received from a Service function chain (SFC) controller; and a received data message is processed according to the received IPv6 transition strategy. By the technical solution, the problems of incapability of a network system in effective running during fusion with an IPv6 transition technology and incapability in effective implementation of unified deployment of the IPv6 transition technology in the related technology are solved, and the effects of effectively reducing performance pressure on an existing network and greatly alleviating channel congestion between equipment and equipment are further achieved.

Abstract: The disclosed embodiments provide a method, system, and device for online ticket checking based on a client interface. The method comprises: receiving a request for an electronic ticket checking interface sent by a client; sending response information to the client after parsing and verifying that identification information of at least one electronic ticket purchased by the client included in the request for an electronic ticket checking interface complies with a ticket checking condition; and receiving password input information acquired by a checking interface sent by the client, comparing whether the password input information is consistent with a password stored in a storage device A of a database, and sending, to the client, ticket checking prompt information based on the result of the comparison.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: Provided are a method, device and system for implementing address sharing. An address pool configured for unified management over IP addresses is configured on an AAA server; and the AAA server may allocate an IP address to a CGN device according to the configured address pool. By such a technology for implementing address sharing in the present disclosure, IP address resource sharing among CGN devices is implemented, so that problems about resource load sharing among the CGN devices may be solved, a sharing rate of IP address resources is increased, and resource optimization may be implemented; and moreover, in terms of IP address management, a more available platform is provided for an operating company. In addition, the IP addresses are managed by the AAA server in a unified manner, and then the address pool is not required to be configured on the CGN device, so that the CGN device may be started without any address pool.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: A compound, enantiomer, prodrug, diastereomer, or salt is provided which is an activator of the enzyme glucokinase and thus is believed to be useful in as treating diabetes and related diseases, which compound has the structure (I). A method for treating diabetes and related disease employing the compound, enantiomer, prodrug, diastereomer, or salt is also provided.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Abstract: A service node capability processing method and apparatus, a service classifier and service controller are described. The method includes: determining an exchange information set of service nodes on a service function chaining for processing a data packet, wherein the exchange information set includes an intersection of capabilities of the service nodes on the service function chaining; and encapsulating the exchange information set in the data packet, wherein the exchange information set is used for the service nodes to read a processing result which is obtained by processing capability corresponding to the intersection of the capabilities of the service nodes and which is encapsulated in the data packet. In such a fashion, the problem in the related technology is addressed that the blind information exchange causes the waste of resources since the information exchange between nodes is untargeted, and consequentially effectively avoids the waste of field resources by invalid information exchange.

Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor (FXR), for example, as agonists. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments, in particular for treating cardiovascular disorders.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, O and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The disclosure discloses a method and device for processing a Service Function Chaining (SFC). The method includes that: the SFC receives a message sent from forwarding equipment; the SFC generates a forwarding table corresponding to the message; and under a condition that a preset state of a forwarding table sending switch is on, the SFC sends the forwarding table to the forwarding equipment to make the forwarding equipment forward the message according to the forwarding table when receiving the message, wherein the forwarding table sending switch is used for indicating the SFC whether to send the forwarding table to the forwarding equipment or not. By the disclosure, an effect of increasing a success rate of data forwarding of the SFC is achieved.